BTG INTERNATIONAL
BTG acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provi... des interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. British Technology Group International that began operation in 1948 became BTG in March 1995. Its headquarters is in London in the United Kingdom.
BTG INTERNATIONAL
Industry:
Biopharma Emergency Medicine Health Care Manufacturing Medical Pharmaceutical
Founded:
1948-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.btgplc.com
Total Employee:
1001+
Status:
Closed
Contact:
+442075750000
Email Addresses:
[email protected]
Total Funding:
11.93 M USD
Technology used in webpage:
Google Font API LetsEncrypt Font Awesome Domain Not Resolving Cloudflare JS CDN JS AJAX Libraries API ASP.NET JQuery CDN Ruby On Rails Token
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-09-07 | Novate Medical | Novate Medical acquired by BTG International | N/A |
| 2017-10-05 | Roxwood Medical | Roxwood Medical acquired by BTG International | N/A |
| 2016-05-05 | Galil Medical | Galil Medical acquired by BTG International | 110 M USD |
| 2014-12-04 | PneumRx | PneumRx acquired by BTG International | 475 M USD |
| 2013-05-23 | EKOS Corporation | EKOS Corporation acquired by BTG International | 220 M USD |
| 2010-11-19 | Biocompatibles International | Biocompatibles International acquired by BTG International | N/A |
| 2008-09-18 | Protherics | Protherics acquired by BTG International | 218.1 M GBP |
| 2005-03-08 | CellMed AG | CellMed AG acquired by BTG International | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-07-17 | New Radiomedicine Technology | BTG International investment in Series B - New Radiomedicine Technology | 116 M CNY |
| 2018-11-14 | Veran Medical Technologies | BTG International investment in Venture Round - Veran Medical Technologies | 20 M USD |
| 2006-05-19 | QuNano | BTG International investment in Series A - QuNano | 6.1 M USD |
| 2004-08-05 | Avera Pharmaceutical | BTG International investment in Series C - Avera Pharmaceutical | 48 M USD |
| 2004-04-28 | Ignios | BTG International investment in Series A - Ignios | 3.8 M USD |
| 2004-02-24 | Protez Pharmaceuticals | BTG International investment in Series A - Protez Pharmaceuticals | N/A |
| 2003-09-10 | Xention | BTG International investment in Venture Round - Xention | 4 M GBP |
| 2003-02-01 | Senexis | BTG International investment in Seed Round - Senexis | 1.4 M GBP |
Official Site Inspections
http://www.btgplc.com
- Host name: ec2-54-68-182-72.us-west-2.compute.amazonaws.com
- IP address: 54.68.182.72
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
